NYSE:HUM (USA) Also trade in: Germany UK

Humana Inc

$ 286.96 0 (0%)
Volume: 834,585 Avg Vol (1m): 1,102,537
Market Cap $: 38.77 Bil Enterprise Value $: 29.93 Bil
P/E (TTM): 15.66 P/B: 3.26
Earnings Power Value 20.75
Net Current Asset Value 0
Tangible Book 57.31
Projected FCF 211.66
Median P/S Value 181.94
Graham Number 153.74
Peter Lynch Value 155.99
DCF (FCF Based) 27.22
DCF (Earnings Based) 236.06
1Y (-%)

Financial Strength : 6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.81
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.77, Max: 27.27
Current: 0.81
0.01
27.27
Equity-to-Asset 0.41
Equity-to-Asset range over the past 10 years
Min: 0.25, Med: 0.38, Max: 0.55
Current: 0.41
0.25
0.55
Debt-to-Equity 0.50
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.42, Max: 0.9
Current: 0.5
0
0.9
Debt-to-EBITDA 1.45
Debt-to-EBITDA range over the past 10 years
Min: 0.74, Med: 1.23, Max: 2.22
Current: 1.45
0.74
2.22
Beneish M-Score -2.51
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 126.78%
WACC 7.38%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Net Margin % 4.13
Net Margin range over the past 10 years
Min: 1.13, Med: 3.05, Max: 4.55
Current: 4.13
1.13
4.55
ROE % 23.33
ROE range over the past 10 years
Min: 5.84, Med: 15.64, Max: 23.85
Current: 23.33
5.84
23.85
ROA % 8.67
ROA range over the past 10 years
Min: 2.45, Med: 6.44, Max: 9.31
Current: 8.67
2.45
9.31
3-Year Total Revenue Growth Rate 1.60
3-Year Revenue Growth Rate range over the past 10 years
Min: -26.1, Med: 9.8, Max: 28.7
Current: 4.6
-26.1
28.7
3-Year Total EBITDA Growth Rate -2.80
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 11.6, Max: 66.2
Current: 0.1
0
66.2
3-Year EPS w/o NRI Growth Rate 12.90
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 5.15, Max: 41.9
Current: 12.9
0
41.9

Ratios

Current vs industry vs history
PE Ratio (TTM) 15.66
PE Ratio range over the past 10 years
Min: 4.26, Med: 13.58, Max: 52.88
Current: 15.66
4.26
52.88
Forward PE Ratio 16.31
N/A
PE Ratio without NRI 15.66
PE without NRI range over the past 10 years
Min: 4.26, Med: 13.58, Max: 52.88
Current: 15.66
4.26
52.88
Price-to-Owner-Earnings 195.08
Price-to-Owner-Earnings range over the past 10 years
Min: 2.73, Med: 10.19, Max: 202.43
Current: 195.08
2.73
202.43
PB Ratio 3.26
PB Ratio range over the past 10 years
Min: 0.71, Med: 1.84, Max: 4.49
Current: 3.26
0.71
4.49
PS Ratio 0.65
PS Ratio range over the past 10 years
Min: 0.11, Med: 0.41, Max: 0.86
Current: 0.65
0.11
0.86
Price-to-Free-Cash-Flow 114.97
Price-to-Free-Cash-Flow range over the past 10 years
Min: 2.77, Med: 9.65, Max: 669.94
Current: 114.97
2.77
669.94
Price-to-Operating-Cash-Flow 40.20
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.5, Med: 7.87, Max: 53.04
Current: 40.2
2.5
53.04
EV-to-EBIT 8.44
EV-to-EBIT range over the past 10 years
Min: -0.7, Med: 4.95, Max: 16.4
Current: 8.44
-0.7
16.4
EV-to-EBITDA 7.32
EV-to-EBITDA range over the past 10 years
Min: -0.6, Med: 4.1, Max: 13.4
Current: 7.32
-0.6
13.4
EV-to-Revenue 0.49
EV-to-Revenue range over the past 10 years
Min: 0.1, Med: 0.3, Max: 0.7
Current: 0.49
0.1
0.7
PEG Ratio 1.91
PEG Ratio range over the past 10 years
Min: 0.15, Med: 1.06, Max: 10.99
Current: 1.91
0.15
10.99
Shiller PE Ratio 28.66
Shiller PE Ratio range over the past 10 years
Min: 10.62, Med: 21.58, Max: 38.8
Current: 28.66
10.62
38.8

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.54
Trailing Dividend Yield range over the past 10 years
Min: 0.3, Med: 0.68, Max: 1.61
Current: 0.54
0.3
1.61
Dividend Payout Ratio 0.08
Dividend Payout Ratio range over the past 10 years
Min: 0.08, Med: 0.14, Max: 0.21
Current: 0.08
0.08
0.21
3-Year Dividend Growth Rate (Per Share) 20.30
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 20.3
Current: 20.3
0
20.3
Forward Dividend Yield % 0.77
N/A
Yield-on-Cost (5-Year) % 1.02
Yield-on-Cost (5y) range over the past 10 years
Min: 0.57, Med: 1.28, Max: 3.03
Current: 1.02
0.57
3.03
3-Year Share Buyback Rate 2.50
3-Year Share Buyback Rate range over the past 10 years
Min: -17.3, Med: -0.35, Max: 2.5
Current: 2.5
-17.3
2.5

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.01
Price-to-Tangible-Book range over the past 10 years
Min: 1.32, Med: 3.46, Max: 12.29
Current: 5.01
1.32
12.29
Price-to-Projected-FCF 1.35
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.29, Med: 0.9, Max: 1.89
Current: 1.35
0.29
1.89
Price-to-DCF (Earnings Based) 1.22
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.27, Med: 0.88, Max: 4.43
Current: 1.22
0.27
4.43
Price-to-Median-PS-Value 1.58
Price-to-Median-PS-Value range over the past 10 years
Min: 0.21, Med: 1.04, Max: 2.7
Current: 1.58
0.21
2.7
Price-to-Peter-Lynch-Fair-Value 1.84
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.23, Med: 0.8, Max: 18.45
Current: 1.84
0.23
18.45
Price-to-Graham-Number 1.87
Price-to-Graham-Number range over the past 10 years
Min: 0.64, Med: 1.8, Max: 6.81
Current: 1.87
0.64
6.81
Earnings Yield (Joel Greenblatt) % 11.85
Earnings Yield (Greenblatt) range over the past 10 years
Min: -3390, Med: 20.1, Max: 4111
Current: 11.85
-3390
4111
Forward Rate of Return (Yacktman) % 12.78
Forward Rate of Return range over the past 10 years
Min: 6.9, Med: 21.8, Max: 42.6
Current: 12.78
6.9
42.6

» HUM's 30-Y Financials

Financials (Next Earnings Date: 2019-11-07)

» Interactive Chart

Peter Lynch Chart

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:HUM

Business Description

Industry Health Care Plans » Health Care Plans    NAICS : 621610    SIC : 6324
Compare NYSE:CI NYSE:CNC NYSE:WCG NYSE:ANTM NYSE:MOH BSP:GNDI3 XPAR:GDS BSP:ODPV3 BSP:QUAL3 NAS:MGLN OSTO:MCOV B OTCPK:HQDA NAS:HIIQ ATH:IATR ROCO:6665 ASX:ONT MIL:HI TSXV:META OSTO:FEEL TSXV:NXG
Traded in other countries 0J6Z.UK
Address 500 West Main Street, Louisville, KY, USA, 40202
Humana Inc is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building an extensive provider network in key geographic areas in order to control the use and cost of healthcare services to its membership. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

More Statistics

Revenue (TTM) (Mil) $ 60,726
EPS (TTM) $ 18.33
Beta 1.09
Volatility % 26.75
52-Week Range $ 225.65 - 355.88
Shares Outstanding (Mil) 135.09

Analyst Estimate

Piotroski F-Score Details